Human amnion-derived mesenchymal stem cells improve subclinical hypothyroidism by immunocompetence mediating apoptosis inhibition on thyroid cells in aged mice.

MLA

Li, Chuyu, et al. “Human Amnion-Derived Mesenchymal Stem Cells Improve Subclinical Hypothyroidism by Immunocompetence Mediating Apoptosis Inhibition on Thyroid Cells in Aged Mice.” Cell and Tissue Research, vol. 394, no. 2, Nov. 2023, pp. 309–23. EBSCOhost, https://doi.org/10.1007/s00441-023-03822-1.

APA

Li, C., Rui, Q., Dong, X., Ning, S., Zhou, J., Wu, H., Jiang, C., Cui, Y., Liu, J., Jiang, J., & Qin, L. (2023). Human amnion-derived mesenchymal stem cells improve subclinical hypothyroidism by immunocompetence mediating apoptosis inhibition on thyroid cells in aged mice. Cell and Tissue Research, 394(2), 309–323. https://doi.org/10.1007/s00441-023-03822-1

Chicago

Li, Chuyu, Qiang Rui, Xiaohan Dong, Song Ning, Jing Zhou, Huimin Wu, Chunyan Jiang, et al. 2023. “Human Amnion-Derived Mesenchymal Stem Cells Improve Subclinical Hypothyroidism by Immunocompetence Mediating Apoptosis Inhibition on Thyroid Cells in Aged Mice.” Cell and Tissue Research 394 (2): 309–23. doi:10.1007/s00441-023-03822-1.